Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Fzd2 is important for skin and hair development through various signaling ways.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Male and female hair loss have different genetic causes.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

Low levels of vitamin D and ferritin may increase the risk of female pattern hair loss.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Lack of vitamin D might cause hair loss due to autoimmune problems, and fixing vitamin D levels could help treat it.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Adequate steroid treatment needed to limit bone loss in PMR patients.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Erdr1 could be a new marker for diagnosing hair loss.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.